rs137854610
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001099404.2(SCN5A):c.5477G>A(p.Arg1826His) variant causes a missense change. The variant allele was found at a frequency of 0.000062 in 1,613,756 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1826C) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.5477G>A | p.Arg1826His | missense_variant | 28/28 | ENST00000413689.6 | |
SCN5A | NM_000335.5 | c.5474G>A | p.Arg1825His | missense_variant | 28/28 | ENST00000423572.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.5477G>A | p.Arg1826His | missense_variant | 28/28 | 5 | NM_001099404.2 | P4 | |
SCN5A | ENST00000423572.7 | c.5474G>A | p.Arg1825His | missense_variant | 28/28 | 1 | NM_000335.5 | A1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249544Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135354
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461636Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 727104
GnomAD4 genome AF: 0.000151 AC: 23AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74296
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 05, 2024 | Variant summary: SCN5A c.5477G>A (p.Arg1826His) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.2e-05 in 1613756 control chromosomes, predominantly at a frequency of 0.00039 within the African or African-American subpopulation in the gnomAD database (v4.0.0). The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 18 fold of the estimated maximal expected allele frequency for a pathogenic variant in SCN5A causing Long QT Syndrome phenotype (2.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.5477G>A has been reported in the literature in individuals affected with Long QT Syndrome and in association with SIDS (Kapplinger_2009, Ackerman_2001) without evidence for causality. These reports do not provide unequivocal conclusions about association of the variant with Long QT Syndrome. At least one publication reports experimental evidence evaluating an impact on protein function in vitro, however the biological impact of this study is unclear (Ackerman_2001). The following publications have been ascertained in the context of this evaluation (PMID: 11710892, 19716085). ClinVar contains an entry for this variant (Variation ID: 9389). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 27, 2018 | The p.Arg1826His variant in SCN5A has been previously reported in 1 infant with SIDS, 2 individuals with LQTS, and 1 individual with infantile-onset of HCM (Ack erman 2001, Kapplinger 2009, LMM data). It has also been identified in 7/24022 A frican chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.bro adinstitute.org; dbSNP rs137854610) and reported in ClinVar (Variation ID 9389). Functional studies have shown that the Arg1826His variant impacts protein funct ion (Ackerman 2001). However, this in vitro assay may not accurately represent b iological function. Additional computational prediction tools and conservation a nalysis suggest that this variant may impact the protein, though this informatio n is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Arg1826His variant is uncertain. ACMG/AMP Criteria applied : PP3; PS4_Supporting; PS3_Supporting. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 01, 2022 | Published in vitro functional studies demonstrate a damaging effect showing slower decay of sodium current and 2-3 fold increase in late sodium current (Ackerman et al., 2001); however, it is unclear how these studies may translate to a pathogenic role in vivo; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25637381, 23304551, 24055113, 23465283, 28316956, 18378609, 30079003, 31043699, 33083721, 32746448, 31657683, 27077130, 11710892, 19716085) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1826 of the SCN5A protein (p.Arg1826His). This variant is present in population databases (rs137854610, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of SCN5A-related conditions (PMID: 11710892, 19716085, 30079003; Invitae). ClinVar contains an entry for this variant (Variation ID: 9389). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SCN5A function (PMID: 11710892). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiac arrhythmia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Feb 05, 2024 | This missense variant replaces arginine with histidine at codon 1826 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). An experimental study has shown that this variant may have impact on the channel function in vitro (PMID: 11710892). This variant has been reported in a case with sudden infant death syndrome (PMID: 11710892) and in an individual affected with long QT syndrome (PMID: 31657683). This variant has been identified in 13/280928 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 27, 2023 | This missense variant replaces arginine with histidine at codon 1826 of the SCN5A protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). An experimental study has shown that this variant may have impact on the channel function in vitro (PMID: 11710892). This variant has been reported in a case with sudden infant death syndrome (PMID: 11710892) and in an individual affected with long QT syndrome (PMID: 31657683). This variant has been identified in 13/280928 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Long QT syndrome 3 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 14, 2001 | - - |
SUDDEN INFANT DEATH SYNDROME Uncertain:1
Uncertain significance, no assertion criteria provided | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | - - |
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 20, 2022 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2022 | The p.R1826H variant (also known as c.5477G>A), located in coding exon 27 of the SCN5A gene, results from a G to A substitution at nucleotide position 5477. The arginine at codon 1826 is replaced by histidine, an amino acid with highly similar properties. This variant was first described in a sudden infant death syndrome (SIDS) cohort; however, in the case involving p.R1826H, the authors indicated the cause of death was undetermined since asphyxiation could not be ruled out. In the same study, functional in vitro analyses suggested this variant may adversely affect the sodium ion channel, resulting in persistent and increased late sodium current related to gain of function effects (Ackerman MJ et al. JAMA. 2001;286(18):2264-9). A second in vitro functional assay did not observe an impact on sodium current at room temperature, but authors observed a decrease in thermal stability at higher temperatures and suggested that the alteration may affect channel function at physiological termperatures (Gardill BR et al. Sci Rep. 2018;8:4483). In a study of long QT syndrome clinical genetic testing, this alteration was reported in two patients; however, clinical details were limited (Kapplinger JD et al. Heart Rhythm. 2009;6(9):1297-303). This variant has been detected in exome cohorts, but cardiovascular history was not provided (Andreasen C et al. Can J Cardio. 2013;29(9):1104-9; Dorschner MO et al. Am J Hum Genet. 2013;93(4):631-40; Amendola LM et al. Genome Res. 2015;25(3):305-15; Jamuar SS et al. EBioMedicine. 2016;5:211-6). An alteration involving the same amino acid position (p.R1826C c.5476C>T) has been described in a patient with paroxysmal atrial fibrillation (Darbar D et al. Circulation. 2008;117(15):1927-35). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:11710892;PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at